These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
347 related articles for article (PubMed ID: 32378459)
1. Application of nanomaterials in treatment, anti-infection and detection of coronaviruses. Nikaeen G; Abbaszadeh S; Yousefinejad S Nanomedicine (Lond); 2020 Jun; 15(15):1501-1512. PubMed ID: 32378459 [TBL] [Abstract][Full Text] [Related]
2. Why have nanotechnologies been underutilized in the global uprising against the coronavirus pandemic? Uskoković V Nanomedicine (Lond); 2020 Jul; 15(17):1719-1734. PubMed ID: 32462968 [TBL] [Abstract][Full Text] [Related]
3. Nanotechnology Responses to COVID-19. Ruiz-Hitzky E; Darder M; Wicklein B; Ruiz-Garcia C; Martín-Sampedro R; Del Real G; Aranda P Adv Healthc Mater; 2020 Oct; 9(19):e2000979. PubMed ID: 32885616 [TBL] [Abstract][Full Text] [Related]
4. How can nanotechnology help to combat COVID-19? Opportunities and urgent need. Campos EVR; Pereira AES; de Oliveira JL; Carvalho LB; Guilger-Casagrande M; de Lima R; Fraceto LF J Nanobiotechnology; 2020 Sep; 18(1):125. PubMed ID: 32891146 [TBL] [Abstract][Full Text] [Related]
5. [Diagnosis, treatment, control and prevention of SARS-CoV-2 and coronavirus disease 2019: back to the future]. Ye ZW; Jin DY Sheng Wu Gong Cheng Xue Bao; 2020 Apr; 36(4):571-592. PubMed ID: 32347053 [TBL] [Abstract][Full Text] [Related]
6. The Potential of Various Nanotechnologies for Coronavirus Diagnosis/Treatment Highlighted through a Literature Analysis. Alphandéry E Bioconjug Chem; 2020 Aug; 31(8):1873-1882. PubMed ID: 32639742 [TBL] [Abstract][Full Text] [Related]
7. Can nanotechnology help in the fight against COVID-19? Palestino G; García-Silva I; González-Ortega O; Rosales-Mendoza S Expert Rev Anti Infect Ther; 2020 Sep; 18(9):849-864. PubMed ID: 32574081 [TBL] [Abstract][Full Text] [Related]
10. Antiviral Activity of Nanomaterials against Coronaviruses. Muhammad W; Zhai Z; Gao C Macromol Biosci; 2020 Oct; 20(10):e2000196. PubMed ID: 32783352 [TBL] [Abstract][Full Text] [Related]
11. COVID-2019: update on epidemiology, disease spread and management. Sahu KK; Mishra AK; Lal A Monaldi Arch Chest Dis; 2020 Apr; 90(1):. PubMed ID: 32297723 [TBL] [Abstract][Full Text] [Related]
12. Toward Nanotechnology-Enabled Approaches against the COVID-19 Pandemic. Weiss C; Carriere M; Fusco L; Capua I; Regla-Nava JA; Pasquali M; Scott JA; Vitale F; Unal MA; Mattevi C; Bedognetti D; Merkoçi A; Tasciotti E; Yilmazer A; Gogotsi Y; Stellacci F; Delogu LG ACS Nano; 2020 Jun; 14(6):6383-6406. PubMed ID: 32519842 [TBL] [Abstract][Full Text] [Related]
13. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2. Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096 [TBL] [Abstract][Full Text] [Related]
14. COVID-19: Main therapeutic options. Hachfi W; Ben Lasfar N Tunis Med; 2020 Apr; 98(4):299-303. PubMed ID: 32395792 [No Abstract] [Full Text] [Related]
15. COVID-19 pandemic: an overview of epidemiology, pathogenesis, diagnostics and potential vaccines and therapeutics. Amawi H; Abu Deiab GI; A Aljabali AA; Dua K; Tambuwala MM Ther Deliv; 2020 Apr; 11(4):245-268. PubMed ID: 32397911 [TBL] [Abstract][Full Text] [Related]
16. Comprehensive Review on Current Interventions, Diagnostics, and Nanotechnology Perspectives against SARS-CoV-2. Chauhan DS; Prasad R; Srivastava R; Jaggi M; Chauhan SC; Yallapu MM Bioconjug Chem; 2020 Sep; 31(9):2021-2045. PubMed ID: 32680422 [TBL] [Abstract][Full Text] [Related]
17. Virology, Epidemiology, Pathogenesis, and Control of COVID-19. Jin Y; Yang H; Ji W; Wu W; Chen S; Zhang W; Duan G Viruses; 2020 Mar; 12(4):. PubMed ID: 32230900 [TBL] [Abstract][Full Text] [Related]
18. Application prospect of polysaccharides in the development of anti-novel coronavirus drugs and vaccines. Chen X; Han W; Wang G; Zhao X Int J Biol Macromol; 2020 Dec; 164():331-343. PubMed ID: 32679328 [TBL] [Abstract][Full Text] [Related]
19. The emergence of a novel coronavirus (SARS-CoV-2) disease and their neuroinvasive propensity may affect in COVID-19 patients. Yashavantha Rao HC; Jayabaskaran C J Med Virol; 2020 Jul; 92(7):786-790. PubMed ID: 32320066 [TBL] [Abstract][Full Text] [Related]
20. An evidence-based systematic review on emerging therapeutic and preventive strategies to treat novel coronavirus (SARS-CoV-2) during an outbreak scenario. Gudadappanavar AM; Benni J J Basic Clin Physiol Pharmacol; 2020 Sep; 31(6):. PubMed ID: 32924964 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]